MicroRNA-29 and fibrosis diseases

Journal of Central South University (Medical Sciences)

Volumn 36, Issue 9, 2011, Pages 908-9132

  Ge, Yan ^a   Chen, Guochun ^a   Sun, Lin ^a   Liu, Fuyou ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Extracellular matrix; Fibrosis diseases; MicroRNA 29

Indexed keywords

EID: 80555138897     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2011.09.017     Document Type: Review

References (41)

1. Kozomara A, Griffiths-Jones S. miRBase : integrating micro-RNA annotation and deep-sequencing data [J]. Nucleic Acids Res, 39 (Database issue) :D152-157.
2. Lagos-Quintana M, Rauhut R, Lendeckel W, et al. Identification of novel genes coding for small expressed RNAs [J]. Science, 2001, 294(5543) :853-858. (Pubitemid 33032103)
3. Lagos-Quintana M, Rauhut R, Yalcin A, et al. Identification of tissue-specific microRNAs from mouse [J]. Curr Biol, 2002, 12(9) : 735-739. (Pubitemid 34455427)
4. Dostie J, Mourelatos Z, Yang M, et al. Numerous microRNPs in neuronal cells containing novel microRNAs [J]. RNA, 2003, 9(2) :180-186. (Pubitemid 36206286)
5. Hwang H W, Wentzel E A, Mendell J T. A hexanucleotide element directs microRNA nuclear import [J]. Science, 2007, 315(5808) :97-100. (Pubitemid 46196987)
6. van Rooij E, Sutherland L B, Thatcher JE, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis [J]. Proc Natl Acad Sei USA, 2008, 105(35) :13027-13032.
7. Cushing L, Kuang P P, Qian J, et al. miR-29 is a major regulator of genes associated with pulmonary fibrosis [J]. Am J Respir Cell Mol Biol, 2011, 45(2) :287-294.
8. Roderburg C, Urban G W, Bettermann K, et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis[J]. Hepatology, 2011, 53(1) :209-218.
9. Feldman A L, Dogan A, Smith DI, et al. Discovery of recurrent t (6; 7) (p25. 3; q32. 3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing [J]. Blood, 117(3) :915-919.
10. Wang H, Garzón R, Sun H, et al. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma [J]. Cancer Cell, 2008, 14(5) :369-381.
11. Chang T C, Yu D, Lee Y S, et al. Widespread microRNA repression by Myc contributes to tumorigenesis [J]. Nat Genet, 2008, 40(1):43-50.
12. Mott J L, Kurita S, Cazanave S C, et al. Transcriptional suppression of mir-29b-l/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB[J]. J Cell Biochem, 2010, 110(5) :1155-1164.
13. Maurer B, Stanczyk J, Jungel A, et al. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis [J]. Arthritis Rheum, 2010, 62(6) :3-1743.
14. Ogawa T, Iizuka M, Sekiya Y, et al. Suppression of Type I collagen production by microRNA-29b in cultured human stellate Cells [J]. Biochem Biophys Res Commun, 2010, 391 (1) : 316-321.
15. Divakaran V, Adrogue J, Ishiyama M, et al. Adaptive and maladptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading [J]. Circ Heart Fail, 2009, 2(6) :633-642.
16. Davis B N, Hilyard A C, Lagna G, et al. SMAD proteins control DROSHA-mediated microRNA maturation [J]. Nature, 2008, 454(7200) :56-61. (Pubitemid 351931982)
17. Long J, Wang Y, Wang W, et al. MicroRNA-29c is a signature MicroRNA under high glucose conditions which targets sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy [J]. J Biol Chem, 2011, 286(13): 11837-11848.
18. Chendrimada T P, Finn K J, Ji X, et al. MicroRNA silencing through RISC recruitment of eIF6[J]. Nature, 2007, 447 (7146) :823-828. (Pubitemid 46920131)
19. Forman J J, Legesse-Miller A, Coller H A. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence [J]. Proc Natl Acad Sei USA, 2008, 105(39) :14879-14884.
20. Ott C E, Grunhagen J, Jager M, et al. MicroRNAs differentially expressed in postnatal aortic development downregulate elastin via 3'UTR and coding-sequence binding sites [J]. PLoS One, 2011, 6(1):el6250.
21. Bartel D P. MicroRNAs; target recognition and regulatory functions [J]. Cell, 2009, 136(2) :215-233.
22. John B, Enright A J, Aravin A, et al. Human microRNA targets [J]. PLoS Biol, 2005, 3(7): e274.
23. Kapinas K, Kessler C B, Delany A M. miR-29 suppression of osteonectin in osteoblasts :regulation during differentiation and by canonical Wnt signaling[J]. J Cell Biochem, 2009, 108 (1) :216-224.
24. Kapinas K, Kessler C, Ricks T, et al. miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop [J]. J Biol Chem, 2010, 285(33) :25221-25231.
25. Sengupta S, den Boon J A, Chen I H, et al. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins [J]. Proc Natl Acad Sei USA, 2008, 105(15) :5874-5878. (Pubitemid 351758465)
26. Li Z, Hassan M Q, Jafferji M, et al. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation [J]. J Biol Chem, 2009, 284(23) :15676-15684.
27. Fort A, Borel C, Migliavacca E, et al. Regulation of fibrinogen production by microRNAs [J]. Blood, 2010, 116 (14) :2608-2615.
28. Park S Y, Lee J H, Ha M, et al. miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42 [J]. Nat Struct Mol Biol, 2009, 16(1):23-29.
29. Mott J L, Kobayashi S, Bronk S F, et al. mir-29 regulates Mcl1 protein expression and apoptosis [J]. Oncogene, 2007, 26 (42) :6133-6140. (Pubitemid 47414372)
30. Garzon R, Heaphy C E, Havelange V, et al. MicroRNA 29b functions in acute myeloid leukemia[J]. Blood, 2009, 114 (26) :5331-5341.
31. Pekařsky Y, Santanam U, Cimmino A, et al. Tell expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181[J]. Cancer Res, 2006, 66(24) :11590-11593. (Pubitemid 46094168)
32. Winbanks C E, Wang B, Beyer C, et al. TGF-1 beta| regulates miR-206 and miR-29 to control myogenic differentiation through regulation of histone deacetylase 4 (HDAC4) [J]. J Biol Chem, 2011, [Epub ahead of print].
33. Fabbri M, Garzon R, Cimmino A, et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B[J]. Proc Natl Acad Sei USA, 2007, 104(40) :15805-15810. (Pubitemid 350035380)
34. Gebeshuber C A, Zatloukal K, Martinez J. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis [J]. EMBO Rep, 2009, 10(4) :400405.
35. Bettens K, Brouwers N, Engelborghs S, et al. APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease [J]. Hum Mutat, 2009, 30(8) :1207-1213.
36. Verrier J D, Lau P, Hudson L, et al. Peripheral myelin protein 22 is regulated post-transcriptionally by miRNA-29a [J]. GHa, 2009, 57(12) :1265-1279.
37. Xu H, Cheung I Y, Guo H F, et al. MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors [J]. Cancer Res, 2009, 69 (15) :6275-6281.
38. Nathans R, Chu C Y, Serquina A K, et al. Cellular microRNA and P bodies modulate host-HIV-1 interactions [J]. Mol Cell, 2009, 34(6) :696-709.
39. Luna C, Li G, Qiu J, et al. Cross-talk between miR-29 and transforming growth factor-betas in trabecular meshwork cells [J]. Invest Ophthalmol Vis Sci, 2011, 52(6) :3567-3572.
40. Castilla M A, Moreno-Bueno G, Romero-Perez L, et al. MicroRNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma [J]. J Pathol, 2011, 223(1) :72-80.
41. Mizuno H, Nakamura A, Aoki Y, et al. Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy [J]. PLoS One, 2011, 6(3):e18388.